RU2222539C2 - Гетероциклические соединения, ингибиторы нейтрофильной эластазы и фармацевтические композиции на их основе - Google Patents

Гетероциклические соединения, ингибиторы нейтрофильной эластазы и фармацевтические композиции на их основе Download PDF

Info

Publication number
RU2222539C2
RU2222539C2 RU2001126725/04A RU2001126725A RU2222539C2 RU 2222539 C2 RU2222539 C2 RU 2222539C2 RU 2001126725/04 A RU2001126725/04 A RU 2001126725/04A RU 2001126725 A RU2001126725 A RU 2001126725A RU 2222539 C2 RU2222539 C2 RU 2222539C2
Authority
RU
Russia
Prior art keywords
group
compound
formula
oxo
valyl
Prior art date
Application number
RU2001126725/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2001126725A (ru
Inventor
Фуминори САТО (JP)
Фуминори САТО
Ясунао ИНОУЕ (JP)
Ясунао ИНОУЕ
Томоки ОМОДАНИ (JP)
Томоки ОМОДАНИ
Ретаро СИРАТАКЕ (JP)
Ретаро СИРАТАКЕ
Сейдзи ХОНДА (JP)
Сейдзи ХОНДА
Масанобу КОМИЯ (JP)
Масанобу КОМИЯ
Тадаси ТАКЕМУРА (JP)
Тадаси ТАКЕМУРА
Original Assignee
Дайниппон Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дайниппон Фармасьютикал Ко., Лтд. filed Critical Дайниппон Фармасьютикал Ко., Лтд.
Publication of RU2001126725A publication Critical patent/RU2001126725A/ru
Application granted granted Critical
Publication of RU2222539C2 publication Critical patent/RU2222539C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
RU2001126725/04A 1999-03-03 2000-02-23 Гетероциклические соединения, ингибиторы нейтрофильной эластазы и фармацевтические композиции на их основе RU2222539C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11/56052 1999-03-03
JP11056052A JP2000256396A (ja) 1999-03-03 1999-03-03 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤

Publications (2)

Publication Number Publication Date
RU2001126725A RU2001126725A (ru) 2003-06-27
RU2222539C2 true RU2222539C2 (ru) 2004-01-27

Family

ID=13016323

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001126725/04A RU2222539C2 (ru) 1999-03-03 2000-02-23 Гетероциклические соединения, ингибиторы нейтрофильной эластазы и фармацевтические композиции на их основе

Country Status (23)

Country Link
US (1) US6835714B1 (enExample)
EP (1) EP1157998B1 (enExample)
JP (1) JP2000256396A (enExample)
KR (1) KR100622709B1 (enExample)
CN (1) CN1183156C (enExample)
AT (1) ATE259376T1 (enExample)
AU (1) AU758739B2 (enExample)
CA (1) CA2362911A1 (enExample)
DE (1) DE60008218T2 (enExample)
DK (1) DK1157998T3 (enExample)
ES (1) ES2215608T3 (enExample)
HK (1) HK1044955B (enExample)
HU (1) HUP0200608A3 (enExample)
IL (2) IL144813A0 (enExample)
MX (1) MXPA01008836A (enExample)
NZ (1) NZ513594A (enExample)
PL (1) PL199136B1 (enExample)
PT (1) PT1157998E (enExample)
RU (1) RU2222539C2 (enExample)
TR (1) TR200102540T2 (enExample)
TW (1) TW534905B (enExample)
WO (1) WO2000052032A1 (enExample)
ZA (1) ZA200106514B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2289887A3 (en) 2000-06-30 2011-07-06 Seikagaku Corporation Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
AR029851A1 (es) 2000-07-21 2003-07-16 Dendreon Corp Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
SK742003A3 (en) 2000-07-21 2003-06-03 Schering Corp Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
US7244721B2 (en) 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
US7012066B2 (en) * 2000-07-21 2006-03-14 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
GB0021315D0 (en) 2000-08-30 2000-10-18 Dainippon Pharmaceutical Co Heterocyclic compounds and intermediates thereof
WO2002026229A1 (en) * 2000-09-29 2002-04-04 Ono Pharmaceutical Co., Ltd. Airway mucus secretion inhibitors
PL371539A1 (en) * 2002-02-05 2005-06-27 Dainippon Pharmaceutical Co, Ltd. Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
ATE438622T1 (de) * 2004-02-27 2009-08-15 Schering Corp 3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
EP2019837B1 (en) * 2006-05-23 2011-03-23 Irm Llc Compounds and compositions as channel activating protease inhibitors
EP2027143A2 (en) * 2006-05-23 2009-02-25 Irm Llc Compounds and compositions as channel activating protease inhibitors
WO2008032331A1 (en) * 2006-09-12 2008-03-20 Himalaya Global Holdings Ltd. Herbal composition for the prevention of wrinkles and skin disorders, methods of preparing the same and uses thereof
CA2677485A1 (en) * 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
CA2677487A1 (en) * 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
US9353113B2 (en) 2011-03-18 2016-05-31 Ono Pharmaceutical Co., Ltd. Tetrahydrocarboline derivative
CN104031014B (zh) * 2013-03-08 2016-05-11 华中师范大学 香豆素衍生物及其制备方法以及弹性蛋白酶活性检测方法和检测试剂盒
CN104165869B (zh) * 2013-05-17 2016-12-28 华中师范大学 一种检测蛋白水解酶活性的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453423A (en) * 1991-04-09 1995-09-26 Boehringer Mannheim Italia S.P.A. Heterocyclic amines useful in the therapy of asthma and imflammation of the respiratory tract
WO1996031214A1 (en) * 1995-04-06 1996-10-10 Eli Lilly And Company 2-acylaminopropanamides as tachykinin receptor antagonists
RU2119913C1 (ru) * 1992-09-30 1998-10-10 Берингер Маннгейм Италиа С.п.А. 1,4-дизамещенные пиперазины, пригодные при лечении астмы и воспаления дыхательных путей, способ их получения, лекарственные препараты на их основе и способ их получения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS231228B1 (en) 1982-10-01 1984-10-15 Evzen Kasafirek Biologically effective tri and tetrapeptide alkylamide derivatives and their processing method
GB8600263D0 (en) 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
GB8809316D0 (en) 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
CA1340191C (en) 1988-06-13 1998-12-15 Katsuhiro Imaki Derivatives of p-substituted phenyl ester of pivalic acid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453423A (en) * 1991-04-09 1995-09-26 Boehringer Mannheim Italia S.P.A. Heterocyclic amines useful in the therapy of asthma and imflammation of the respiratory tract
RU2119913C1 (ru) * 1992-09-30 1998-10-10 Берингер Маннгейм Италиа С.п.А. 1,4-дизамещенные пиперазины, пригодные при лечении астмы и воспаления дыхательных путей, способ их получения, лекарственные препараты на их основе и способ их получения
WO1996031214A1 (en) * 1995-04-06 1996-10-10 Eli Lilly And Company 2-acylaminopropanamides as tachykinin receptor antagonists

Also Published As

Publication number Publication date
HK1044955B (zh) 2005-07-08
CN1183156C (zh) 2005-01-05
KR100622709B1 (ko) 2006-09-13
PT1157998E (pt) 2004-06-30
EP1157998B1 (en) 2004-02-11
AU758739B2 (en) 2003-03-27
EP1157998A4 (en) 2003-01-29
IL144813A (en) 2006-12-10
KR20020002396A (ko) 2002-01-09
JP2000256396A (ja) 2000-09-19
CA2362911A1 (en) 2000-09-08
US6835714B1 (en) 2004-12-28
ES2215608T3 (es) 2004-10-16
HK1044955A1 (en) 2002-11-08
TW534905B (en) 2003-06-01
DE60008218T2 (de) 2004-12-09
TR200102540T2 (tr) 2002-01-21
MXPA01008836A (es) 2002-05-14
NZ513594A (en) 2003-04-29
HUP0200608A3 (en) 2002-09-30
IL144813A0 (en) 2002-06-30
DK1157998T3 (da) 2004-06-14
EP1157998A1 (en) 2001-11-28
ZA200106514B (en) 2002-05-10
HUP0200608A2 (en) 2002-08-28
CN1349542A (zh) 2002-05-15
ATE259376T1 (de) 2004-02-15
AU2690200A (en) 2000-09-21
WO2000052032A1 (en) 2000-09-08
DE60008218D1 (de) 2004-03-18
PL199136B1 (pl) 2008-08-29

Similar Documents

Publication Publication Date Title
RU2336275C2 (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью, и фармацевтическая композиция
RU2001126725A (ru) Гетероциклические соединения, их промежуточные продукты и ингибиторы эластазы
RU2221798C2 (ru) Имидазонафтиридины, фармацевтическая композиция на их основе, способ стимуляции биосинтеза цитокина и промежуточные вещества
RU2405780C2 (ru) Химические соединения
RU2481346C2 (ru) Ингибиторы фосфатидилинозитол-3-киназы
AR045595A1 (es) Composiciones utiles como inhibidores de proteinas quinasas
AR046422A1 (es) Acidos carboxilicos macrociclicos y acilsulfonamidas como inhibidores de la replicacion del vhc
AR036046A1 (es) Inhibidores de la hiv proteasa, composiciones que las contienen y sus usos farmaceuticos
MA30352B1 (fr) Pyridine [3,4-b] pyrazinones
RU2000126474A (ru) Производные индола, обладающие антивирусной активностью
RU2004130488A (ru) Пиримидиновые производные
PE20030865A1 (es) Composiciones farmaceuticas para inhibidores de proteasa viral de la hepatitis c
AR016499A1 (es) Compuestos de pirrolo[2,3-d]pirimidina, composiciones y procesos para su uso en medicina.
UA88909C2 (ru) Ингибиторы рнк-зависимой рнк-полимеразы вируса гепатита с, фармацевтическая композиция на их основе и их применение
AR039563A1 (es) Derivados de 4-(imidazol-5-il)-2-(4-sulfoanilino)pirimidina con actividad inhibidora de cdk
ATE367386T1 (de) Triazolverbindungen zur behandlung von dysmenorrhoe
RU2003134153A (ru) Дипептиды, содержащие на n-концевом аминокислотном остатке 2-тиоацильную группу, в качестве ингибиторов вазопептидазы
CO5611155A2 (es) Uso de derivado de indolopirrolocarbazol y otro agente anticanceroso en combinacion
JP2004529145A5 (enExample)
EA200400140A1 (ru) Пероральные противодиабетические агенты
AR045999A1 (es) Compuesto de eter de piperidina, su uso para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para prepararlo
RU2401267C2 (ru) Замещенные производные бензохинолизина
EA200400690A1 (ru) Нуклеозиды, их препараты и их применение в качестве ингибиторов вирусных рнк-полимераз
CO5640109A2 (es) Compuestos triciclicos inhibidores de la farnesisl proteino transferasa y composiciones farmaceuticas que los contienen
NZ513594A (en) Heterocyclic compounds, intermediates thereof and elastase inhibitors

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
MM4A The patent is invalid due to non-payment of fees

Effective date: 20100224